HHS announced that CDC will award $140 million for COVID-19 vaccine preparedness and almost $87 million for tracking and testing to 64 jurisdictions, including all 50 states and U.S. territories. Authorized through the CARES Act, the COVID-19 vaccines preparedness funding will provide infrastructure support to existing grantees through the Immunizations and Vaccines for Children cooperative agreement. These funds, along with previous support of $200 million allocated in September, will help awardees prepare to distribute COVID-19 vaccines. Authorized through the PPPHCEA, the testing and tracking funding will provide support to existing CDC grantees through the agency’s Epidemiology and Laboratory Capacity for Prevention and Control of Emerging Infectious Diseases (ELC) Cooperative Agreement. These eligible uses of the funding includes: increasing the use of Advanced Molecular Detection technologies, such as whole genome sequencing of SARS-CoV-2; strengthening public health laboratory preparedness; and ensuring safe travel through optimized data sharing and communication with international travelers.